We are live on !
Find out more
Aperio Group Portfolio holdings
AUM
$33.8B
Turnover
6.32%
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$33.8B
AUM Growth
+$4.19B
(+14%)
Cap. Flow
+$264M
Cap. Flow % of AUM
Cap. Flow %
0.78%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.4
years
Top 20 Avg Time Held
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$52.4M |
| 2 |
Tesla
TSLA
|
+$42.1M |
| 3 |
Microsoft
MSFT
|
+$16.9M |
| 4 |
Walt Disney
DIS
|
+$14.5M |
| 5 |
Morgan Stanley
MS
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever NV New York Registry Shares
UN
|
+$48.8M |
| 2 |
AT&T
T
|
+$25.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$20M |
| 4 |
Amazon
AMZN
|
+$15.7M |
| 5 |
Biogen
BIIB
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.68% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.35% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2026
Harmony Gold Mining
HMY
$10.6B
| $438K | ﹤0.01% |
93,682
+6,991
| +8% | +$34.5K |
2014 Q1
27 quarters
|
|
2027
Independent Bank Corp
IBCP
$799M
| $438K | ﹤0.01% |
23,712
+5,114
| +27% | +$83.8K |
2020 Q2
2 quarters
|
|
|
ALTA
2028
DELISTED
Altabancorp
ALTA
| $438K | ﹤0.01% |
15,700
-182
| -1% | -$4.62K |
2020 Q2
2 quarters
|
|
2029
O-I Glass
OI
$928M
| $437K | ﹤0.01% |
36,736
-8,160
| -18% | -$93.1K |
2014 Q1
27 quarters
|
|
2030
Unisys
UIS
$174M
| $437K | ﹤0.01% |
22,213
-722
| -3% | -$10.4K |
2018 Q2
10 quarters
|
|
2031
Del Monte Corp
DMC
$1.32B
| $436K | ﹤0.01% |
18,116
-328
| -2% | -$7.91K |
2013 Q4
28 quarters
|
|
2032
Travere Therapeutics
TVTX
$4.96B
| $436K | ﹤0.01% |
15,981
+650
| +4% | +$15.2K |
2018 Q4
8 quarters
|
|
2033
CRISPR Therapeutics
CRSP
$4.88B
| $435K | ﹤0.01% |
+2,838
| New | +$335K |
2020 Q4
0 quarters
|
|
2034
Frontdoor
FTDR
$5.57B
| $432K | ﹤0.01% |
+8,603
| New | +$393K |
2020 Q4
0 quarters
|
|
2035
AtriCure
ATRC
$2.93B
| $431K | ﹤0.01% |
7,750
-2
| -0% | -$86 |
2018 Q3
9 quarters
|
|
2036
CTS Corp
CTS
$1.61B
| $429K | ﹤0.01% |
+12,498
| New | +$370K |
2020 Q4
0 quarters
|
|
2037
Benchmark Electronics
BHE
$2.56B
| $428K | ﹤0.01% |
15,861
+2,765
| +21% | +$65.3K |
2014 Q4
24 quarters
|
|
2038
National Energy Services Reunited Corp
NESR
$2.19B
| $426K | ﹤0.01% |
42,916
+140
| +0.3% | +$1.16K |
2019 Q4
4 quarters
|
|
2039
DELISTED
Infinera Corporation Common Stock
INFN
| $426K | ﹤0.01% |
40,696
-669
| -2% | -$5.3K |
2016 Q4
16 quarters
|
|
|
MGP
2040
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $426K | ﹤0.01% |
13,612
+3,669
| +37% | +$109K |
2020 Q1
3 quarters
|
|
2041
Viasat
VSAT
$8.62B
| $421K | ﹤0.01% |
12,907
-633
| -5% | -$21.8K |
2018 Q4
8 quarters
|
|
2042
TriNet
TNET
$3.26B
| $420K | ﹤0.01% |
5,215
-45
| -0.9% | -$3.33K |
2019 Q1
7 quarters
|
|
|
IBA
2043
DELISTED
Industrias Bachoco SAB De C.V.
IBA
| $420K | ﹤0.01% |
9,294
+82
| +0.9% | +$3.34K |
2014 Q1
27 quarters
|
|
2044
Myriad Genetics
MYGN
$533M
| $417K | ﹤0.01% |
21,088
+770
| +4% | +$12.4K |
2017 Q1
15 quarters
|
|
|
GBT
2045
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $417K | ﹤0.01% |
9,629
+2,053
| +27% | +$101K |
2019 Q2
6 quarters
|
|
2046
Loma Negra
LOMA
$1.12B
| $416K | ﹤0.01% |
67,675
| – | – |
2020 Q3
1 quarter
|
|
|
AEGN
2047
DELISTED
Aegion Corp
AEGN
| $414K | ﹤0.01% |
21,789
+3,952
| +22% | +$66.2K |
2015 Q1
23 quarters
|
|
2048
Adtran
ADTN
$545M
| $413K | ﹤0.01% |
27,976
+1,185
| +4% | +$15K |
2018 Q3
9 quarters
|
|
2049
HCI Group
HCI
$2.54B
| $412K | ﹤0.01% |
7,883
-1,906
| -19% | -$96.3K |
2018 Q2
10 quarters
|
|
2050
Liberty Energy
LBRT
$2.72B
| $412K | ﹤0.01% |
39,961
+1,392
| +4% | +$12.7K |
2019 Q4
4 quarters
|
|
Similar funds
LCM
Aperio Group's Q4 2020 Portfolio in Review
As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
- Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
- Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
- Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
- Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
- Aperio Group opened 104 new positions and closed 53 in Q4 2020.
- Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.